Israel Englander Harvard Bioscience Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Millennium Management LLC holds 11,952 shares of HBIO stock, worth $25,577. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,952

Previous 148,422 91.95%

Holding current value

$25,577

Previous $423,000 92.43%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.64 - $3.54 $360,280 - $483,103	-136,470 Reduced 91.95%	11,952 $32,000
Q2 2024 Aug 14, 2024	BUY	$2.77 - $4.63 $358,584 - $599,367	129,453 Added 682.45%	148,422 $423,000
Q1 2024 May 15, 2024	SELL	$4.02 - $5.39 $176,502 - $236,653	-43,906 Reduced 69.83%	18,969 $80,000
Q4 2023 Feb 14, 2024	SELL	$4.0 - $5.49 $811,100 - $1.11 Million	-202,775 Reduced 76.33%	62,875 $336,000
Q2 2023 Aug 14, 2023	BUY	$4.19 - $6.16 $554,232 - $814,814	132,275 Added 99.18%	265,650 $1.46 Million
Q1 2023 May 15, 2023	SELL	$2.45 - $4.22 $75,594 - $130,208	-30,855 Reduced 18.79%	133,375 $560,000
Q4 2022 Feb 14, 2023	SELL	$2.12 - $2.86 $87,931 - $118,624	-41,477 Reduced 20.16%	164,230 $455,000
Q3 2022 Nov 14, 2022	SELL	$2.33 - $3.92 $431,653 - $726,215	-185,259 Reduced 47.38%	205,707 $527,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $1.03 Million - $2.02 Million	314,413 Added 410.71%	390,966 $1.41 Million
Q1 2022 May 16, 2022	SELL	$5.16 - $7.14 $86,662 - $119,916	-16,795 Reduced 17.99%	76,553 $475,000
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $305,142 - $391,846	-47,903 Reduced 33.91%	93,348 $658,000
Q3 2021 Nov 15, 2021	SELL	$6.98 - $8.47 $30,090 - $36,514	-4,311 Reduced 2.96%	141,251 $986,000
Q2 2021 Aug 16, 2021	BUY	$5.44 - $8.4 $468,155 - $722,887	86,058 Added 144.63%	145,562 $1.21 Million
Q1 2021 May 17, 2021	BUY	$3.91 - $6.99 $166,253 - $297,214	42,520 Added 250.35%	59,504 $325,000
Q4 2020 Feb 16, 2021	SELL	$3.0 - $4.5 $105,396 - $158,094	-35,132 Reduced 67.41%	16,984 $73,000
Q3 2020 Nov 16, 2020	BUY	$2.75 - $4.2 $9,047 - $13,818	3,290 Added 6.74%	52,116 $157,000
Q2 2020 Aug 14, 2020	SELL	$2.12 - $3.14 $1.03 Million - $1.53 Million	-486,400 Reduced 90.88%	48,826 $151,000
Q1 2020 May 14, 2020	BUY	$1.42 - $3.29 $36,505 - $84,579	25,708 Added 5.05%	535,226 $1.18 Million
Q4 2019 Feb 14, 2020	SELL	$2.45 - $3.25 $332,741 - $441,392	-135,813 Reduced 21.05%	509,518 $1.55 Million
Q3 2019 Nov 14, 2019	SELL	$1.59 - $3.47 $670,989 - $1.46 Million	-422,006 Reduced 39.54%	645,331 $1.98 Million
Q2 2019 Aug 15, 2019	BUY	$1.93 - $4.59 $1.94 Million - $4.63 Million	1,007,707 Added 1689.93%	1,067,337 $2.14 Million
Q2 2019 Aug 14, 2019	SELL	$1.93 - $4.59 $30,117 - $71,626	-15,605 Reduced 20.74%	59,630 $1.06 Million
Q1 2019 May 14, 2019	BUY	$2.77 - $4.38 $158,335 - $250,365	57,161 Added 316.26%	75,235 $324,000
Q4 2018 Feb 14, 2019	SELL	$3.03 - $5.0 $307,093 - $506,755	-101,351 Reduced 84.87%	18,074 $57,000
Q3 2018 Nov 14, 2018	BUY	$5.0 - $6.65 $295,360 - $392,828	59,072 Added 97.88%	119,425 $627,000
Q2 2018 Aug 14, 2018	SELL	$4.2 - $5.95 $694,117 - $983,332	-165,266 Reduced 73.25%	60,353 $323,000
Q1 2018 May 15, 2018	BUY	$3.3 - $5.15 $673,721 - $1.05 Million	204,158 Added 951.3%	225,619 $1.13 Million
Q4 2017 Feb 14, 2018	SELL	$3.08 - $3.8 $100,922 - $124,514	-32,767 Reduced 60.42%	21,461 $71,000
Q3 2017 Nov 14, 2017	BUY	$2.7 - $3.75 $146,415 - $203,355	54,228	54,228 $203,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

30.6M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account